Related references
Note: Only part of the references are listed.Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori et al.
ANNALS OF INTERNAL MEDICINE (2009)
The ACCORD Trial and Control of Blood Glucose Level in Type 2 Diabetes Mellitus Time to Challenge Conventional Wisdom
Stephen Havas
ARCHIVES OF INTERNAL MEDICINE (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
DIABETES CARE (2009)
Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes The DIAD Study: A Randomized Controlled Trial
Lawrence H. Young et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intensive glycemic control and cardiovascular disease observations from the ACCORD study - Now what can a clinician possibly think?
William T. Cefalu et al.
DIABETES (2008)
The benefit of aspirin therapy in type 2 diabetes:: What is the evidence?
Caroline Sirois et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Intensive glycemic control in the ACCORD and ADVANCE trials
Robert G. Dluhy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
ENHANCE and ACCORD: Controversy over surrogate end points
Steven E. Nissen
Current Cardiology Reports (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Statistics in medicine - Reporting of subgroup analyses in clinical trials
Rui Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Action to control cardiovascular risk in diabetes (ACCORD) trial: Design and methods
John B. Buse
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes -: Early Treatment Diabetic Retinopathy Study Report no. 27
M Cusick et al.
DIABETES CARE (2005)
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: Results of the Primary Prevention Project (PPP) trial
M Sacco et al.
DIABETES CARE (2003)
Showing neuropathy is related to increased mortality in diabetic patients -: a survival analysis using an accelerated failure time model
DV Coppini et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
